ATE380820T1 - Murine alpha(1,3)-fucosyltransferase (fuc-tvii) - Google Patents

Murine alpha(1,3)-fucosyltransferase (fuc-tvii)

Info

Publication number: ATE380820T1
Authority: AT; Austria
Prior art keywords: fucosyltransferase; tvii; fuc; murine alpha; murine
Prior art date: 1996-03-08

Application number

AT97908788T

Other languages

English (en)

Inventor

Shunji Natsuka

Kevin Gersten

John Lowe

Original Assignee

Univ Michigan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-08

Filing date

1997-03-07

Publication date

2007-12-15

1997-03-07 Application filed by Univ Michigan filed Critical Univ Michigan

2007-12-15 Application granted granted Critical

2007-12-15 Publication of ATE380820T1 publication Critical patent/ATE380820T1/de

Links

102100021333 Alpha-(1,3)-fucosyltransferase 7 Human genes 0.000 title abstract 2
101000819503 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 Proteins 0.000 title abstract 2
101001022183 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 Proteins 0.000 title abstract 2
101001022175 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 Proteins 0.000 title abstract 2
101000862183 Homo sapiens Alpha-(1,3)-fucosyltransferase 10 Proteins 0.000 title abstract 2
101000862213 Homo sapiens Alpha-(1,3)-fucosyltransferase 11 Proteins 0.000 title abstract 2
101000819497 Homo sapiens Alpha-(1,3)-fucosyltransferase 7 Proteins 0.000 title abstract 2
241001529936 Murinae Species 0.000 title abstract 2
NIGUVXFURDGQKZ-UQTBNESHSA-N alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O NIGUVXFURDGQKZ-UQTBNESHSA-N 0.000 abstract 1
210000000265 leukocyte Anatomy 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
230000002194 synthesizing effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Pain & Pain Management (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Public Health (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT97908788T 1996-03-08 1997-03-07 Murine alpha(1,3)-fucosyltransferase (fuc-tvii) ATE380820T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US61309896A	1996-03-08	1996-03-08

Publications (1)

Publication Number	Publication Date
ATE380820T1 true ATE380820T1 (de)	2007-12-15

Family

ID=24455853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97908788T ATE380820T1 (de)	1996-03-08	1997-03-07	Murine alpha(1,3)-fucosyltransferase (fuc-tvii)

Country Status (7)

Country	Link
US (2)	US6693183B2 (de)
EP (1)	EP0888377B1 (de)
JP (1)	JP2000507095A (de)
AT (1)	ATE380820T1 (de)
AU (1)	AU731261B2 (de)
DE (1)	DE69738368T2 (de)
WO (1)	WO1997032889A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5858752A (en) *	1995-06-07	1999-01-12	The General Hospital Corporation	Fucosyltransferase genes and uses thereof
US6713283B2 (en)	1998-01-29	2004-03-30	The Board Of Regents Of The University Of Oklahoma	Tyrosylprotein sulfotransferases
US6204016B1 (en)	1998-01-29	2001-03-20	The Board Of Regents Of The University Of Oklahoma	Tyrosylprotein sulfotransferases and methods of use thereof
US6605455B1 (en)	1998-01-29	2003-08-12	The Board Of Regsnts Of The University Of Oklahoma	Tyrosylprotein sulfotransferases and methods of use thereof
US6071732A (en) *	1998-01-29	2000-06-06	The Board Of Regents Of The University Of Oklahoma	Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof
US7029890B2 (en)	1998-01-29	2006-04-18	Siwa Biotech Corporation	Tyrosylprotein sulfotransferases and methods of use thereof
US6207432B1 (en)	1998-01-29	2001-03-27	The Board Of Regents Of The University Of Oklahoma	Tyrosylprotein sulfotransferases and methods of use thereof
US6060295A (en) *	1998-01-29	2000-05-09	The Board Of Regents Of The University Of Oklahoma	Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases
AU2957199A (en) *	1998-03-24	1999-10-18	Kyowa Hakko Kogyo Co. Ltd.	Antibody against human alpha1,3-fucose transferase fuc-tvii
NZ522320A (en) *	2000-05-12	2007-03-30	Neose Technologies Inc	In vitro modification of glycosylation patterns of recombinant glycopeptides
US7173003B2 (en) *	2001-10-10	2007-02-06	Neose Technologies, Inc.	Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US8008252B2 (en)	2001-10-10	2011-08-30	Novo Nordisk A/S	Factor VII: remodeling and glycoconjugation of Factor VII
US7214660B2 (en) *	2001-10-10	2007-05-08	Neose Technologies, Inc.	Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7157277B2 (en)	2001-11-28	2007-01-02	Neose Technologies, Inc.	Factor VIII remodeling and glycoconjugation of Factor VIII
DE60336555D1 (de) *	2002-06-21	2011-05-12	Novo Nordisk Healthcare Ag	Pegylierte glykoformen von faktor vii
AU2004221824B2 (en) *	2003-03-14	2009-08-27	Ratiopharm Gmbh	Branched water-soluble polymers and their conjugates
CA2522345A1 (en) *	2003-04-09	2004-11-18	Neose Technologies, Inc.	Glycopegylation methods and proteins/peptides produced by the methods
US8791070B2 (en)	2003-04-09	2014-07-29	Novo Nordisk A/S	Glycopegylated factor IX
US7932364B2 (en) *	2003-05-09	2011-04-26	Novo Nordisk A/S	Compositions and methods for the preparation of human growth hormone glycosylation mutants
WO2005012484A2 (en) *	2003-07-25	2005-02-10	Neose Technologies, Inc.	Antibody-toxin conjugates
US20080305992A1 (en)	2003-11-24	2008-12-11	Neose Technologies, Inc.	Glycopegylated erythropoietin
US8633157B2 (en) *	2003-11-24	2014-01-21	Novo Nordisk A/S	Glycopegylated erythropoietin
ES2422187T3 (es) *	2003-12-03	2013-09-09	Biogenerix Ag	Factor estimulante de colonias de granulocitos glicopegilados
US20060040856A1 (en)	2003-12-03	2006-02-23	Neose Technologies, Inc.	Glycopegylated factor IX
NZ548123A (en) *	2004-01-08	2010-05-28	Novo Nordisk As	O-linked glycosylation of peptides
WO2006010143A2 (en)	2004-07-13	2006-01-26	Neose Technologies, Inc.	Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
WO2006020372A2 (en) *	2004-07-23	2006-02-23	Neose Technologies, Inc.	Enzymatic modification of glycopeptides
WO2006031811A2 (en) *	2004-09-10	2006-03-23	Neose Technologies, Inc.	Glycopegylated interferon alpha
EP1814573B1 (de)	2004-10-29	2016-03-09	ratiopharm GmbH	Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
CA2593682C (en) *	2005-01-10	2016-03-22	Neose Technologies, Inc.	Glycopegylated granulocyte colony stimulating factor
US9187546B2 (en)	2005-04-08	2015-11-17	Novo Nordisk A/S	Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20080255026A1 (en)	2005-05-25	2008-10-16	Glycopegylated Factor 1X	Glycopegylated Factor Ix
US20110003744A1 (en) *	2005-05-25	2011-01-06	Novo Nordisk A/S	Glycopegylated Erythropoietin Formulations
FI20055398A0 (fi)	2005-07-08	2005-07-08	Suomen Punainen Risti Veripalv	Menetelmä solupopulaatioiden evaluoimiseksi
US20070105755A1 (en) *	2005-10-26	2007-05-10	Neose Technologies, Inc.	One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en)	2005-11-03	2009-02-19	Neose Technologies, Inc.	Nucleotide Sugar Purification Using Membranes
CN101516388B (zh) *	2006-07-21	2012-10-31	诺和诺德公司	通过o-联糖基化序列的肽的糖基化
US8969532B2 (en) *	2006-10-03	2015-03-03	Novo Nordisk A/S	Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
WO2008060780A2 (en) *	2006-10-04	2008-05-22	Novo Nordisk A/S	Glycerol linked pegylated sugars and glycopeptides
EP2144923B1 (de) *	2007-04-03	2013-02-13	BioGeneriX AG	Behandlungsverfahren mit glycopegyliertem g-csf
EP2162535A4 (de) *	2007-06-04	2011-02-23	Novo Nordisk As	O-verknüpfte glykosylierung unter verwendung von n-acetylglucosaminyl-transferasen
WO2008154639A2 (en) *	2007-06-12	2008-12-18	Neose Technologies, Inc.	Improved process for the production of nucleotide sugars
US8207112B2 (en) *	2007-08-29	2012-06-26	Biogenerix Ag	Liquid formulation of G-CSF conjugate
CN102037004A (zh) *	2008-01-08	2011-04-27	生物种属学股份公司	使用寡糖基转移酶的多肽的糖缀合
US20130189239A1 (en)	2008-02-27	2013-07-25	Novo Nordisk A/S	Conjugated Factor VIII Molecules
EP2166085A1 (de)	2008-07-16	2010-03-24	Suomen Punainen Risti Veripalvelu	Divalente modifizierte Zellen
SG10201404280XA (en) *	2009-07-21	2014-10-30	Abt Holding Co	Use of stem cells to reduce leukocyte extravasation
AU2010276264B2 (en) *	2009-07-21	2013-09-19	Abt Holding Company	Use of stem cells to reduce leukocyte extravasation
US9692789B2 (en)	2013-12-13	2017-06-27	Oracle International Corporation	Techniques for cloud security monitoring and threat intelligence
US9616114B1 (en)	2014-09-18	2017-04-11	David Gordon Bermudes	Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en)	2015-05-11	2020-06-09	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en)	2016-12-07	2021-09-28	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en)	2016-12-07	2021-11-23	David Gordon Bermudes	Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994023021A1 (fr) *	1993-03-29	1994-10-13	Kyowa Hakko Kogyo Co., Ltd.	α-1,3-FUCOSYLTRANSFERASE
US5858752A (en) *	1995-06-07	1999-01-12	The General Hospital Corporation	Fucosyltransferase genes and uses thereof
US5858750A (en) *	1997-11-25	1999-01-12	Incyte Pharmaceuticals, Inc.	Human retinol dehydrogenase type II homolog

1997
- 1997-03-07 JP JP9531850A patent/JP2000507095A/ja not_active Ceased
- 1997-03-07 WO PCT/US1997/003184 patent/WO1997032889A1/en not_active Ceased
- 1997-03-07 AU AU20608/97A patent/AU731261B2/en not_active Ceased
- 1997-03-07 DE DE69738368T patent/DE69738368T2/de not_active Expired - Lifetime
- 1997-03-07 AT AT97908788T patent/ATE380820T1/de not_active IP Right Cessation
- 1997-03-07 EP EP97908788A patent/EP0888377B1/de not_active Expired - Lifetime
2001
- 2001-02-16 US US09/784,077 patent/US6693183B2/en not_active Expired - Lifetime
2003
- 2003-11-05 US US10/700,505 patent/US7723080B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7723080B2 (en)	2010-05-25
US20020111469A1 (en)	2002-08-15
US20040063178A1 (en)	2004-04-01
JP2000507095A (ja)	2000-06-13
WO1997032889A1 (en)	1997-09-12
EP0888377A1 (de)	1999-01-07
AU2060897A (en)	1997-09-22
DE69738368D1 (de)	2008-01-24
AU731261B2 (en)	2001-03-29
DE69738368T2 (de)	2008-12-04
US6693183B2 (en)	2004-02-17
EP0888377A4 (de)	2001-12-05
EP0888377B1 (de)	2007-12-12

Legal Events

Date	Code	Title	Description
2008-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69738368D1 (de)	2008-01-24	MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
IT1302347B1 (it)	2000-09-05	Procedimento per la produzione diretta di perossido di idrogeno.
HUP0202759A2 (hu)	2002-12-28	Táptalaj sejtek fehérjementes és szérummentes tenyésztéséhez
CA2167521A1 (en)	1995-02-16	Compositions and methods for producing sialyltransferases
DK0960109T3 (da)	2002-11-25	Fremgangsmåde til fremstilling af tolterodin
AP9400666A0 (en)	1994-10-31	Benzofuran derivatives.
AU6226198A (en)	1998-09-22	Improved methods of making cross-bridged macropolycycles
IT1267464B1 (it)	1997-02-05	Procedimento per la produzione di carburo di ferro.
NO943323D0 (no)	1994-09-08	Sammensetninger og fremgangsmåte for identifisering og syntese av sialyltransferaser
BG102016A (en)	1998-11-30	Method for the diagnostics of schizophrenia
DE69331484D1 (de)	2002-03-14	N-Acetylglucosaminyl-Transferase, dafür kodierendes Gen, entsprechende Vektoren und transformierte Wirte und Herstellungsverfahren dafür
AU4823993A (en)	1994-04-26	Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof
EP0733709A3 (de)	1998-06-03	Mutierte Farnesyldiphosphatesynthase befähigt zum Synthetisieren von Geranylgeranyldiphosphat und dafür kodierende Gene
MY131172A (en)	2007-07-31	6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd) indoles
AU1170501A (en)	2001-05-30	Cubic boron nitride clusters
IL139773A0 (en)	2002-02-10	Morphine-6-glucuronide synthesis
GB2341391B (en)	2002-01-09	Cloning of UDP-galactose epimerase
YU62800A (sh)	2002-11-15	Postupak za proizvodnju r-(+)-6- karboksamido-3n-metilamino- 1,2,3,4-tetrahidrokarbazola
DE69637429D1 (de)	2008-03-27	Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
CA2247966A1 (en)	1997-09-12	Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof
AU2455600A (en)	2000-06-13	Apoptosis-inducing factor
AU5369399A (en)	2000-01-17	Basic refractory ceramic hollow body
CA2281226A1 (en)	2000-03-03	Process for synthesizing .alpha.-substituted ring systems
AUPR414701A0 (en)	2001-05-03	Alpha 1,3 galactosyltransferase
DE59914061D1 (de)	2007-01-25	Das gen prv-1 und dessen verwendung